Trial Profile
A Study to Evaluate the Efficacy of Dolutegravir Monotherapy in Heavily Pretreated HIV-1-Infected Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Jun 2016
Price :
$35
*
At a glance
- Drugs Dolutegravir (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 17 Jun 2016 New trial record
- 10 Jun 2016 Results published in the Journal of Antimicrobial Chemotherapy